Lawrence E. Crane

Array ( [id] => 5887484 [patent_doc_number] => 20060275239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Depolymerized scleroglucan for regulating and improving the moisture content of the skin' [patent_app_type] => utility [patent_app_number] => 11/448953 [patent_app_country] => US [patent_app_date] => 2006-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3885 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275239.pdf [firstpage_image] =>[orig_patent_app_number] => 11448953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 132275 [patent_doc_number] => 07700761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-20 [patent_title] => '3-deoxypentopyranosyl nucleic acid, its production and its use' [patent_app_type] => utility [patent_app_number] => 11/445037 [patent_app_country] => US [patent_app_date] => 2006-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8871 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700761.pdf [firstpage_image] =>[orig_patent_app_number] => 11445037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7693953 [patent_doc_number] => 20070015733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-18 [patent_title] => 'Aryl Phosphate Derivatives of d4T having Activity Against Resistant HIV Strains' [patent_app_type] => utility [patent_app_number] => 11/420973 [patent_app_country] => US [patent_app_date] => 2006-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 25638 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20070015733.pdf [firstpage_image] =>[orig_patent_app_number] => 11420973 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 914551 [patent_doc_number] => 07326694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-05 [patent_title] => 'Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders' [patent_app_type] => utility [patent_app_number] => 11/420694 [patent_app_country] => US [patent_app_date] => 2006-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11159 [patent_no_of_claims] => 134 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/326/07326694.pdf [firstpage_image] =>[orig_patent_app_number] => 11420694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 849196 [patent_doc_number] => 07381714 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-06-03 [patent_title] => 'A1 adenosine receptor agonists' [patent_app_type] => utility [patent_app_number] => 11/437774 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21168 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/381/07381714.pdf [firstpage_image] =>[orig_patent_app_number] => 11437774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5046537 [patent_doc_number] => 20070265211 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-15 [patent_title] => 'Novel composition and method effective in inhibiting the atherogenic process' [patent_app_type] => utility [patent_app_number] => 11/432830 [patent_app_country] => US [patent_app_date] => 2006-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5329 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20070265211.pdf [firstpage_image] =>[orig_patent_app_number] => 11432830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5835369 [patent_doc_number] => 20060247200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Methods and uses of leukotriene B4 hydroxylases to treat diseases' [patent_app_type] => utility [patent_app_number] => 11/414896 [patent_app_country] => US [patent_app_date] => 2006-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10347 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20060247200.pdf [firstpage_image] =>[orig_patent_app_number] => 11414896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5733495 [patent_doc_number] => 20060258612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'CFTR channel modulators' [patent_app_type] => utility [patent_app_number] => 11/408911 [patent_app_country] => US [patent_app_date] => 2006-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7677 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20060258612.pdf [firstpage_image] =>[orig_patent_app_number] => 11408911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 84123 [patent_doc_number] => 07741473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Process for the preparation of 4,6-disubstituted-tetrahydro-furo, thieno, pyrrolo and cyclopenta-[3,4][1,3]dioxoles' [patent_app_type] => utility [patent_app_number] => 11/393374 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10565 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741473.pdf [firstpage_image] =>[orig_patent_app_number] => 11393374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074595 [patent_doc_number] => 08552174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Solutions, methods, and processes for deprotection of polynucleotides' [patent_app_type] => utility [patent_app_number] => 11/387269 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 37988 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11387269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035320 [patent_doc_number] => 20070099859 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Phosphorus protecting groups' [patent_app_type] => utility [patent_app_number] => 11/388339 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12751 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099859.pdf [firstpage_image] =>[orig_patent_app_number] => 11388339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6497686 [patent_doc_number] => 20100093992 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'Macromolecular Nucleotide Compounds and Methods for Using the Same' [patent_app_type] => utility [patent_app_number] => 11/886518 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 38223 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20100093992.pdf [firstpage_image] =>[orig_patent_app_number] => 11886518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164530 [patent_doc_number] => 08173619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/886931 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9382 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11886931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164530 [patent_doc_number] => 08173619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/886931 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9382 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11886931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164530 [patent_doc_number] => 08173619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/886931 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9382 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11886931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164530 [patent_doc_number] => 08173619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 11/886931 [patent_app_country] => US [patent_app_date] => 2006-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9382 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11886931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7545241 [patent_doc_number] => 08053212 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-11-08 [patent_title] => 'Non-standard nucleoside analogs with reduced epimerization' [patent_app_type] => utility [patent_app_number] => 11/372400 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 15464 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053212.pdf [firstpage_image] =>[orig_patent_app_number] => 11372400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5694745 [patent_doc_number] => 20060154892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-13 [patent_title] => 'Procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis' [patent_app_type] => utility [patent_app_number] => 11/371116 [patent_app_country] => US [patent_app_date] => 2006-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9615 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0154/20060154892.pdf [firstpage_image] =>[orig_patent_app_number] => 11371116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608001 [patent_doc_number] => 20060269517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Use of alpha-glucosidase inhibitors to treat alphavirus infections' [patent_app_type] => utility [patent_app_number] => 11/370535 [patent_app_country] => US [patent_app_date] => 2006-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 65825 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269517.pdf [firstpage_image] =>[orig_patent_app_number] => 11370535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5080250 [patent_doc_number] => 20070123474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Novel loganin analogues and a process for the preparation thereof' [patent_app_type] => utility [patent_app_number] => 11/366687 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7233 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123474.pdf [firstpage_image] =>[orig_patent_app_number] => 11366687 [rel_patent_id] =>[rel_patent_doc_number] =>)